These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

408 related articles for article (PubMed ID: 15270716)

  • 1. Cell-penetrating peptides do not cross mitochondrial membranes even when conjugated to a lipophilic cation: evidence against direct passage through phospholipid bilayers.
    Ross MF; Filipovska A; Smith RA; Gait MJ; Murphy MP
    Biochem J; 2004 Nov; 383(Pt. 3):457-68. PubMed ID: 15270716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell-penetrating peptides are excluded from the mitochondrial matrix.
    Ross MF; Murphy MP
    Biochem Soc Trans; 2004 Dec; 32(Pt 6):1072-4. PubMed ID: 15506968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alternative mechanisms for the interaction of the cell-penetrating peptides penetratin and the TAT peptide with lipid bilayers.
    Yesylevskyy S; Marrink SJ; Mark AE
    Biophys J; 2009 Jul; 97(1):40-9. PubMed ID: 19580742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Membrane binding and translocation of cell-penetrating peptides.
    Thorén PE; Persson D; Esbjörner EK; Goksör M; Lincoln P; Nordén B
    Biochemistry; 2004 Mar; 43(12):3471-89. PubMed ID: 15035618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved cellular activity of antisense peptide nucleic acids by conjugation to a cationic peptide-lipid (CatLip) domain.
    Koppelhus U; Shiraishi T; Zachar V; Pankratova S; Nielsen PE
    Bioconjug Chem; 2008 Aug; 19(8):1526-34. PubMed ID: 18646838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, cellular uptake and HIV-1 Tat-dependent trans-activation inhibition activity of oligonucleotide analogues disulphide-conjugated to cell-penetrating peptides.
    Turner JJ; Arzumanov AA; Gait MJ
    Nucleic Acids Res; 2005; 33(1):27-42. PubMed ID: 15640444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The neuroprotective efficacy of cell-penetrating peptides TAT, penetratin, Arg-9, and Pep-1 in glutamic acid, kainic acid, and in vitro ischemia injury models using primary cortical neuronal cultures.
    Meloni BP; Craig AJ; Milech N; Hopkins RM; Watt PM; Knuckey NW
    Cell Mol Neurobiol; 2014 Mar; 34(2):173-81. PubMed ID: 24213248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endocytosis and membrane potential are required for HeLa cell uptake of R.I.-CKTat9, a retro-inverso Tat cell penetrating peptide.
    Zhang X; Jin Y; Plummer MR; Pooyan S; Gunaseelan S; Sinko PJ
    Mol Pharm; 2009; 6(3):836-48. PubMed ID: 19278221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting peptide nucleic acid (PNA) oligomers to mitochondria within cells by conjugation to lipophilic cations: implications for mitochondrial DNA replication, expression and disease.
    Muratovska A; Lightowlers RN; Taylor RW; Turnbull DM; Smith RA; Wilce JA; Martin SW; Murphy MP
    Nucleic Acids Res; 2001 May; 29(9):1852-63. PubMed ID: 11328868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accumulation of lipophilic dications by mitochondria and cells.
    Ross MF; Da Ros T; Blaikie FH; Prime TA; Porteous CM; Severina II; Skulachev VP; Kjaergaard HG; Smith RA; Murphy MP
    Biochem J; 2006 Nov; 400(1):199-208. PubMed ID: 16948637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cationic cell-penetrating peptide CPP(TAT) derived from the HIV-1 protein TAT is rapidly transported into living fibroblasts: optical, biophysical, and metabolic evidence.
    Ziegler A; Nervi P; Dürrenberger M; Seelig J
    Biochemistry; 2005 Jan; 44(1):138-48. PubMed ID: 15628854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uptake of analogs of penetratin, Tat(48-60) and oligoarginine in live cells.
    Thorén PE; Persson D; Isakson P; Goksör M; Onfelt A; Nordén B
    Biochem Biophys Res Commun; 2003 Jul; 307(1):100-7. PubMed ID: 12849987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peptide-glycosaminoglycan cluster formation involving cell penetrating peptides.
    Rullo A; Qian J; Nitz M
    Biopolymers; 2011 Oct; 95(10):722-31. PubMed ID: 21538329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tat(48-60) peptide amino acid sequence is not unique in its cell penetrating properties and cell-surface glycosaminoglycans inhibit its cellular uptake.
    Subrizi A; Tuominen E; Bunker A; Róg T; Antopolsky M; Urtti A
    J Control Release; 2012 Mar; 158(2):277-85. PubMed ID: 22100438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein transduction domains of HIV-1 and SIV TAT interact with charged lipid vesicles. Binding mechanism and thermodynamic analysis.
    Ziegler A; Blatter XL; Seelig A; Seelig J
    Biochemistry; 2003 Aug; 42(30):9185-94. PubMed ID: 12885253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitochondrial accumulation of a lipophilic cation conjugated to an ionisable group depends on membrane potential, pH gradient and pK(a): implications for the design of mitochondrial probes and therapies.
    Finichiu PG; James AM; Larsen L; Smith RA; Murphy MP
    J Bioenerg Biomembr; 2013 Feb; 45(1-2):165-73. PubMed ID: 23180142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficient intracellular delivery of nucleic acid pharmaceuticals using cell-penetrating peptides.
    Nakase I; Akita H; Kogure K; Gräslund A; Langel U; Harashima H; Futaki S
    Acc Chem Res; 2012 Jul; 45(7):1132-9. PubMed ID: 22208383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. siRNA and pharmacological inhibition of endocytic pathways to characterize the differential role of macropinocytosis and the actin cytoskeleton on cellular uptake of dextran and cationic cell penetrating peptides octaarginine (R8) and HIV-Tat.
    Al Soraj M; He L; Peynshaert K; Cousaert J; Vercauteren D; Braeckmans K; De Smedt SC; Jones AT
    J Control Release; 2012 Jul; 161(1):132-41. PubMed ID: 22465675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. No entry for TAT(44-57) into liposomes and intact MDCK cells: novel approach to study membrane permeation of cell-penetrating peptides.
    Krämer SD; Wunderli-Allenspach H
    Biochim Biophys Acta; 2003 Jan; 1609(2):161-9. PubMed ID: 12543377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinct uptake routes of cell-penetrating peptide conjugates.
    Lundin P; Johansson H; Guterstam P; Holm T; Hansen M; Langel U; EL Andaloussi S
    Bioconjug Chem; 2008 Dec; 19(12):2535-42. PubMed ID: 19012426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.